Pharma & HealthcareTop Companies
Pharma & Healthcare

Top Breast Imaging Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Pharma & Healthcare

Published

Feb 2026

Share:

Pharma & Healthcare

Top Breast Imaging Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
5.60 Billion
2026 Forecast (US$)
6.00 Billion
2032 Forecast (US$)
9.00 Billion
CAGR (2025-2032)
7.10%

Summary

The Breast Imaging market is entering a robust expansion phase, driven by rising screening volumes, AI-enhanced diagnostics, and value-based care models. Global leaders increasingly consolidate share through integrated imaging ecosystems and service contracts. With the market growing from US$ 5.60 Billion in 2025 to US$ 9.00 Billion by 2032, a 7.10% CAGR underscores sustained structural demand.

2025 Revenue of Top Breast Imaging Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of Breast Imaging market companies in this analysis are built on a composite, multi-factor score. Core criteria include estimated 2025 Breast Imaging revenue, segment growth versus the overall 7.10% CAGR, and share of new system installations. We also weigh installed base, breadth of modality coverage across mammography, ultrasound, MRI, molecular imaging, and emerging contrast-enhanced solutions. Technology differentiation, such as AI-enabled workflow, cloud connectivity, and dose-optimization capabilities, contributes significantly to scores. In addition, we assess service reach, multiyear maintenance contracts, and managed imaging service models. Strategic indicators such as M&A activity, partnerships with cancer centers, clinical trial participation, and regulatory approvals further refine rankings. Each company receives a normalized score across these dimensions, and final positions reflect both scale and strategic momentum.

Top 10 Companies in Breast Imaging

1
GE HealthCare Technologies Inc.
Senographe Pristina, Invenia ABUS, SenoBright HD
Expanded Pristina AI suite, partnerships with U.S. screening networks, investment in cloud-native imaging platforms
Chicago, USA
AI-enabled imaging suites, workflow orchestration, enterprise service contracts
Digital mammography, tomosynthesis, contrast-enhanced mammography, breast ultrasound
US$ 1.20 Billion
2
Siemens Healthineers AG
MAMMOMAT Revelation, MAGNETOM Suite, Acuson Sequoia
Launched AI-based reading tools, expanded managed imaging services in Europe and the Middle East
Erlangen, Germany
Integrated diagnostics, AI reading assistants, precision oncology ecosystems
Mammography, breast MRI, ultrasound, molecular imaging
US$ 1.05 Billion
3
Hologic, Inc.
Selenia Dimensions, Genius 3D, Affirm biopsy system
Broadened AI-enhanced 3D mammography portfolio, deepened collaborations with major screening initiatives
Marlborough, USA
Screening leadership, biopsy integration, population-based programs
3D mammography, biopsy systems, analytics
US$ 950.00 Million
4
Koninklijke Philips N.V.
Ingenia Elition, EPIQ Elite, IntelliSpace PACS
Expanded breast MRI coil portfolio, integrated AI tools into reading workflows across Europe and North America
Amsterdam, Netherlands
MR-based breast pathways, image-guided therapy, data-driven care
Breast MRI, ultrasound, informatics
US$ 650.00 Million
5
FUJIFILM Holdings Corporation
Amulet Innovality, Harmony, Synapse
Deployed large-scale screening fleets in Asia, launched AI decision-support packages for mammography
Tokyo, Japan
Affordable screening solutions, emerging market expansion, cloud PACS
Digital mammography, ultrasound, informatics
US$ 480.00 Million
6
Canon Medical Systems Corporation
Aplio i-series, Vantage Galan, Aquilion
Introduced breast-focused ultrasound packages, expanded collaborations with Japanese cancer centers
Tochigi, Japan
Radiation dose reduction, multimodality breast pathways, integrated AI
Ultrasound, CT, MRI for breast applications
US$ 360.00 Million
7
Shimadzu Corporation
Trinias, Sonialvision, MobileDaRt
Strengthened distributor network in Latin America, introduced upgraded mammography workstation software
Kyoto, Japan
Cost-effective mammography platforms, regional channel partnerships
Mammography, X-ray systems
US$ 240.00 Million
8
Carestream Health, Inc.
DRX-Evolution, DRX-Compass, Vue PACS
Launched DR retrofit packages for mammography, extended financing options for small providers
Rochester, USA
Retrofit mammography, budget imaging for community hospitals
DR systems, mammography, IT solutions
US$ 210.00 Million
9
Planmed Oy
Planmed Clarity, Planmed Nuance
Deployed mobile mammography fleets in Eastern Europe, enhanced ergonomic design for patient comfort
Helsinki, Finland
Compact systems, mobile screening units, niche markets
Mammography, breast tomosynthesis
US$ 120.00 Million
10
Metaltronica S.p.A.
Helianthus series
Won public screening tenders in Southern Europe, upgraded systems for tomosynthesis readiness
Rome, Italy
Value-focused mammography, regional tender participation
Digital mammography systems
US$ 90.00 Million

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

GE HealthCare Technologies Inc.

Global imaging leader offering comprehensive Breast Imaging portfolios, integrating hardware, AI, and workflow tools for screening and diagnostic centers.

Key Financials: 2025 Breast Imaging revenue US$ 1.20 Billion; segment growth estimated slightly above overall 7.10% market CAGR.
Flagship Products: Senographe Pristina, Invenia ABUS, SenoBright HD
2025-2026 Actions: Scaling AI-assisted tomosynthesis, expanding enterprise service contracts, and investing in cloud-native image management platforms.
Three-line SWOT: Extensive global installed base and service footprint; Complex portfolio can slow focused innovation; Opportunity—enterprise deals with large screening networks worldwide.
Notable Customers: U.S. national screening chains, leading European university hospitals, major private radiology groups
2

Siemens Healthineers AG

Diversified medtech giant integrating Breast Imaging with broader diagnostic and oncology ecosystems for hospitals and cancer centers worldwide.

Key Financials: 2025 Breast Imaging revenue US$ 1.05 Billion; strong recurring revenue from service and managed imaging contracts.
Flagship Products: MAMMOMAT Revelation, MAGNETOM Suite, Acuson Sequoia
2025-2026 Actions: Launched AI reading assistants, expanded breast MRI packages, and deepened precision oncology partnerships.
Three-line SWOT: Integrated multi-modality portfolio and strong R&D; Complex organization may slow niche customization; Opportunity—growth in comprehensive cancer centers and hybrid imaging.
Notable Customers: University hospital networks, European screening programs, Middle Eastern tertiary care hospitals
3

Hologic, Inc.

Specialist in women’s health and Breast Imaging with leading 3D mammography and biopsy solutions targeting high-volume screening programs.

Key Financials: 2025 Breast Imaging revenue US$ 950.00 Million; high-margin recurring revenue from disposables and service contracts.
Flagship Products: Selenia Dimensions, Genius 3D, Affirm biopsy system
2025-2026 Actions: Expanded AI-enhanced 3D mammography, integrated biopsy workflows, and increased investments in population screening partnerships.
Three-line SWOT: Strong brand in mammography and biopsy; Dependence on breast segment raises concentration risk; Opportunity—expansion into emerging market screening initiatives.
Notable Customers: National screening programs, specialized breast centers, large U.S. outpatient imaging chains
4

Koninklijke Philips N.V.

Global health technology company emphasizing breast MRI, ultrasound, and informatics to support personalized oncology pathways.

Key Financials: 2025 Breast Imaging revenue US$ 650.00 Million; growing contribution from software and informatics subscriptions.
Flagship Products: Ingenia Elition, EPIQ Elite, IntelliSpace PACS
2025-2026 Actions: Enhanced breast MRI coils, integrated AI into reporting, and expanded remote reading solution deployments.
Three-line SWOT: Strong MR and informatics portfolio; Limited standalone mammography presence; Opportunity—rapid adoption of MRI in high-risk screening cohorts.
Notable Customers: Comprehensive cancer centers, academic research institutions, integrated delivery networks
5

FUJIFILM Holdings Corporation

Imaging and informatics provider with strong positions in digital mammography and IT, especially in Asia and emerging markets.

Key Financials: 2025 Breast Imaging revenue US$ 480.00 Million; above-market growth in Asia Pacific screening programs.
Flagship Products: Amulet Innovality, Harmony, Synapse
2025-2026 Actions: Expanded mobile screening fleets, rolled out AI mammography tools, and increased focus on cloud-based PACS platforms.
Three-line SWOT: Competitive pricing and strong channel network; Lower brand recognition in some Western markets; Opportunity—government-funded screening expansions in Asia.
Notable Customers: Public health screening agencies, regional hospital groups, diagnostic imaging centers
6

Canon Medical Systems Corporation

Diagnostic imaging vendor focusing on low-dose CT, MRI, and ultrasound for integrated breast diagnostic pathways.

Key Financials: 2025 Breast Imaging revenue US$ 360.00 Million; steady growth driven by ultrasound and breast MRI packages.
Flagship Products: Aplio i-series, Vantage Galan, Aquilion
2025-2026 Actions: Launched breast-focused ultrasound bundles, strengthened AI-assisted lesion characterization tools, and expanded oncology collaborations.
Three-line SWOT: Strong engineering in image quality and low dose; Limited dedicated mammography portfolio; Opportunity—expanding role of ultrasound in dense-breast screening.
Notable Customers: Japanese cancer centers, regional hospital networks, private diagnostic chains in Asia
7

Shimadzu Corporation

Imaging manufacturer providing cost-effective mammography and X-ray platforms, targeting budget-constrained facilities and regional tenders.

Key Financials: 2025 Breast Imaging revenue US$ 240.00 Million; margin supported by standardized, value-focused platforms.
Flagship Products: Trinias, Sonialvision, MobileDaRt
2025-2026 Actions: Reinforced Latin American distribution, upgraded mammography workstations, and enhanced integration with hospital IT systems.
Three-line SWOT: Competitive pricing and reliable hardware; Limited premium technology differentiation; Opportunity—expansion in mid-tier hospitals across emerging economies.
Notable Customers: Public hospitals, regional clinics, Latin American diagnostic providers
8

Carestream Health, Inc.

Provider of DR and IT solutions with retrofit options enabling economical upgrades of existing mammography infrastructure.

Key Financials: 2025 Breast Imaging revenue US$ 210.00 Million; solid growth in retrofit and upgrade projects.
Flagship Products: DRX-Evolution, DRX-Compass, Vue PACS
2025-2026 Actions: Launched retrofit DR mammography packages, broadened financing models, and enhanced PACS analytics for Breast Imaging workflows.
Three-line SWOT: Strong retrofit value proposition; Smaller R&D budget versus larger OEMs; Opportunity—digitization of legacy analog mammography sites globally.
Notable Customers: Community hospitals, independent imaging centers, regional health systems
9

Planmed Oy

Specialized European manufacturer of compact mammography and tomosynthesis systems suited for mobile and space-constrained environments.

Key Financials: 2025 Breast Imaging revenue US$ 120.00 Million; niche growth from mobile screening and private clinics.
Flagship Products: Planmed Clarity, Planmed Nuance
2025-2026 Actions: Expanded mobile fleet deployments, improved ergonomics for patient comfort, and refined tomosynthesis image reconstruction algorithms.
Three-line SWOT: Niche expertise and compact designs; Limited geographic scale and marketing reach; Opportunity—demand for mobile screening in underserved regions.
Notable Customers: Mobile screening providers, private imaging clinics, regional hospitals in Europe
10

Metaltronica S.p.A.

Italian manufacturer focused on value-oriented digital mammography systems for regional tenders and smaller providers.

Key Financials: 2025 Breast Imaging revenue US$ 90.00 Million; stable revenue from public-sector tenders.
Flagship Products: Helianthus series
2025-2026 Actions: Won new tenders in Southern Europe, prepared upgrades for tomosynthesis, and streamlined production to maintain cost competitiveness.
Three-line SWOT: Competitive tender pricing and local relationships; Limited R&D scale for rapid innovation; Opportunity—upgrading installed base to digital and tomosynthesis.
Notable Customers: Public screening programs, regional hospitals, private diagnostic centers in Southern Europe

SWOT Leaders

GE HealthCare Technologies Inc.

SWOT Snapshot

SWOT
Strengths

Extensive global installed base, comprehensive modality coverage, and strong AI capabilities integrated into Breast Imaging workflows.

Weaknesses

Complex product portfolio may increase lifecycle management costs and complicate customer procurement decisions.

Opportunities

Enterprise-wide imaging and service contracts with large screening networks and integrated health systems globally.

Threats

Intensifying price competition and regulatory scrutiny on AI-enabled imaging tools in key markets.

Siemens Healthineers AG

SWOT Snapshot

SWOT
Strengths

Integrated diagnostics ecosystem, deep R&D capabilities, and strong presence in advanced MRI and molecular Breast Imaging.

Weaknesses

Premium pricing can limit penetration in cost-sensitive emerging markets and smaller clinics.

Opportunities

Growth in comprehensive cancer centers seeking multi-modality imaging and data integration solutions.

Threats

Macroeconomic pressure on capital budgets and competition from focused Breast Imaging specialists.

Hologic, Inc.

SWOT Snapshot

SWOT
Strengths

Market-leading 3D mammography installed base, strong brand recognition, and deep expertise in biopsy workflows.

Weaknesses

High dependence on Breast Imaging segment and limited diversification across other imaging modalities.

Opportunities

Expansion of national screening programs and growing demand for tomosynthesis in dense-breast populations.

Threats

Potential reimbursement changes and new 3D mammography entrants eroding pricing power and margins.

Breast Imaging Market Regional Competitive Landscape

North America remains the largest revenue contributor, driven by high screening uptake, advanced tomosynthesis adoption, and strong reimbursement frameworks. GE HealthCare Technologies Inc., Hologic, Inc., and Siemens Healthineers AG dominate hospital and outpatient imaging networks, while Breast Imaging market companies increasingly compete through AI value propositions and managed service agreements.

Europe shows balanced growth, supported by organized national screening programs and strong public sector purchasing. Siemens Healthineers AG, GE HealthCare Technologies Inc., and FUJIFILM Holdings Corporation hold leading positions, while Planmed Oy and Metaltronica S.p.A. win tenders for value-oriented solutions. Sustainability requirements and data-sovereignty rules shape platform choices among Breast Imaging market companies.

Asia Pacific is the fastest-growing region, underpinned by expanding government-backed screening initiatives and rising private insurance coverage. FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, and GE HealthCare Technologies Inc. gain share through localized manufacturing and broad channel networks. Many Breast Imaging market companies tailor offerings for dense-breast populations and constrained infrastructure environments.

Latin America presents diverse market maturity, with major urban centers installing advanced tomosynthesis while rural regions rely on mobile screening fleets. Shimadzu Corporation, Carestream Health, Inc., and FUJIFILM Holdings Corporation leverage competitively priced systems and distributor partnerships. Currency volatility and public budget cycles significantly influence capital purchase timing for Breast Imaging market companies.

The Middle East and Africa region sees growing investments in comprehensive cancer centers, particularly in Gulf Cooperation Council countries and South Africa. Siemens Healthineers AG and GE HealthCare Technologies Inc. anchor many flagship projects, offering integrated diagnostic suites. Breast Imaging market companies increasingly bundle training, IT integration, and long-term service to mitigate workforce constraints.

Emerging Central and Eastern European markets increasingly modernize outdated mammography fleets through EU-funded programs and regional tenders. Planmed Oy, Metaltronica S.p.A., and larger OEMs like Philips compete for these upgrades. Breast Imaging market companies that provide mobile units, financing solutions, and interoperable IT platforms are best positioned to capture upcoming replacement waves.

Breast Imaging Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

TheraMammo AI
Disruptor
USA

Cloud-native AI platform offering vendor-agnostic triage, density scoring, and risk stratification that overlays existing systems from incumbent Breast Imaging market companies.

NovaBreast Imaging Solutions
Disruptor
Germany

Develops portable, low-power breast ultrasound scanners with integrated AI, targeting underserved screening settings and complementing mammography portfolios.

DeepScan Diagnostics
Disruptor
India

Software-as-a-service provider delivering AI-assisted reporting, quality control dashboards, and workload balancing for high-volume government screening programs.

LuminiScan Medical
Disruptor
Israel

Innovates non-ionizing, multi-spectral Breast Imaging technology aiming to reduce radiation exposure and enable frequent monitoring in high-risk patients.

MammoFleet Mobility
Disruptor
Brazil

Specializes in turnkey mobile screening units with tele-radiology connectivity, enabling rapid deployment of national programs in remote geographies.

Breast Imaging Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Breast Imaging market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Breast Imagingmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.